Vector Laboratories' blog provides a wealth of information on immunohistochemistry (IHC), immunofluorescence (IF), and related life science research topics.
Cancer remains one of the deadliest diseases in the world because we still haven’t fully comprehended why and how it occurs. This article will highlight some areas within cancer research utilizing glycobiology.
Parthiv Haldipur is a researcher focused on developmental neuroscience with a quest to better understand brain development and its effects from conception throughout adulthood.
For the first time in 2022, all employees—remote and in-office—gathered at the new home for Vector Laboratories to celebrate our relocation and our accomplishments so far in 2022.
Silicon Valley Business Journal. Lisa Sellers, PhD, CEO of Vector Laboratories, was nominated and selected to be in the 2022 Class of Women of Influence. Read her interview.
Biocompare. Erika Leonard, Director of Quality Control and R&D, Vector Laboratories, provides insights into common IHC issues and ways of resolving them.
Erika Leonard, Director of R&D, has been with Vector Laboratories for almost 30 years. We sat down to discuss her time at the company and the various roles she’s taken on.
Identifying sources of non-specific staining is crucial for determining potential solutions to improve your staining results. This blog post will briefly walk you through commonly encountered sources of non-specific staining in IHC and IF applications.
Learn about the impact of IL-17 accumulation on cognitive impairment in this blog post for Alzheimer’s Awareness Month.
Check out this innovative article about cancer research to learn how immunohistochemistry is helping scientists improve diagnostics, identify new therapeutic targets, and boost surgical outcomes.
Cancer remains one of the deadliest diseases in the world because we still haven’t fully comprehended why and how it occurs. This article will highlight some areas within cancer research utilizing glycobiology.
